Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

http://www.wikidata.org/entity/Q37728377

about

Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.The effect of the Ras homolog gene family (Rho), member A/Rho associated coiled-coil forming protein kinase pathway in atrial fibrosis of type 2 diabetes in rats.The effect of Chinese Jinzhida recipe on the hippocampus in a rat model of diabetes-associated cognitive decline Complex regulation of PKCβ2 and PDK-1/AKT by ROCK2 in diabetic heart.A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling Pericytes, microvasular dysfunction, and chronic rejection.Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic rats Diabetes-induced increased oxidative stress in cardiomyocytes is sustained by a positive feedback loop involving Rho kinase and PKCβ2.Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation The Protective Effect of Low-Dose Ethanol on Myocardial Fibrosis through Downregulating the JNK Signaling Pathway in Diabetic Rats.Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus.The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models.The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.Effects of the Rho kinase inhibitor, hydroxyfasudil, on bladder dysfunction and inflammation in rats with HCl-induced cystitis.In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles.Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.Progressive Decrease in Coronary Vascular Function Associated With Type 2 Diabetic Heart Disease.MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion.

P2860

Q26799594-801975A8-E01A-4655-8179-1FD212A8EDC8 Q26825697-831AE0EC-D47A-4F7F-97F8-2CFD87ADB545 Q28484372-B8507630-854F-4239-81F5-E45AC8B85A18 Q33713641-A005DC03-06FA-4779-8563-8029833ADBF3 Q33962681-BA7F6322-7896-4C12-81ED-789E8DA63B5C Q34800307-564F44E3-2837-4638-8B60-9A95FA313589 Q35086234-170FC49E-080E-4840-A288-4F2DCD2F794F Q35129485-23B51AE5-45A7-4D97-AE39-9171CA727DC6 Q35672804-12D940A9-4803-4279-A08C-794FC0CE0B35 Q35681643-114BA775-9B21-45E9-8C39-2559DBF2A081 Q35875059-D424BAF5-DA88-48F1-9473-430B61E4B2B9 Q36128353-CA848958-89E7-4F0E-9A05-A2F0EF5AC4F4 Q36159672-591F8CD0-131B-4CD2-8844-354D55568E3F Q36307139-22DC9410-80DE-464C-AF55-5707C0DDA7E3 Q36312528-B85A16B0-7FD7-491F-B455-0DD33B6D1F63 Q36592624-C47D8B54-B9C4-45BF-9F0C-F1EFEABD91E5 Q37071805-CDF155BB-354F-4AC4-AE86-E6C4D30B6773 Q37172092-3A158C97-668F-4EFF-81CA-7F16451B0219 Q39250080-325B96F6-565D-408E-86CA-55DF4BA41C17 Q39398383-2653BEBB-BCD0-4EFE-A63C-72694AFDE121 Q39872619-F1EA5734-C492-43CD-8D05-519061CFF3EE Q42142672-15AD52B0-2D9D-4CA3-831B-1DBD6F34319D Q42368137-5FFF6F58-03A0-45EF-8B1C-B0217F52FEF9 Q47811951-0E87C445-D79B-4184-A803-BDE88539CFEC Q49203906-037015F7-908C-4884-B6BE-97B9CC9F6A9E Q50977301-500C44C8-9DB4-4886-8440-7E7A45D978E2 Q51272863-750000F1-DF28-4606-B85B-489BE6ECECD1 Q52319606-91A01B1A-5B4A-43F1-A192-20392A1D3E95 Q52923562-5B1299BD-9FF3-482C-8E4D-C58E7381B833 Q55000595-1D448BA3-8009-4D96-B1A5-14F5EE2F8C21 Q55190286-8946890D-C53D-475B-A848-975B3D40A7CF Q55438558-5ABE81EA-6085-42F0-A926-974B3BB50EBF

P2860

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

http://www.wikidata.org/entity/Q37728377

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@en

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@nl

type

label

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@en

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@nl

prefLabel

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@en

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@nl

P1433

Q37728377-E04010A5-50A6-489C-A213-2A15157FB9E6

P1476

Q37728377-97C742A6-C848-4B54-9A24-1D504032AC5F

P2093

Q37728377-2919B0F4-76F1-4300-BFEB-2239C9BA5A18

Q37728377-2C41C1ED-B03F-4C44-9970-1326AC54B55B

Q37728377-52456BD1-FE28-444D-8686-A59EA084B322

Q37728377-6B23720A-3CFE-42C5-878E-D6CCDDBC1EA3

Q37728377-7136FCF1-DFF8-4CB0-8A43-6B46A8BB8DBC

Q37728377-7215730C-0448-4C59-A5AD-73DC111C93C8

Q37728377-A03BAF07-344F-4104-B24D-3F72B6FD685D

Q37728377-BFD49429-0BD4-4F5B-AEA0-C4DB0FEF0532

Q37728377-D0AB922A-A342-468C-A704-83630317D201

P2860

Q37728377-01DB3D95-2794-48B3-A4D5-1B12260D5871

Q37728377-07CD2C81-6925-46E8-8FA4-E657953717FD

Q37728377-08A0F3CF-490F-40D3-9C33-7B9F8CB29329

Q37728377-0B97B0A7-9B51-4426-9AB7-6CE800F1FD61

Q37728377-0D338BEF-46C1-41DB-A0B3-2EEDBDE96AC8

Q37728377-1E484847-9D70-4301-B37C-4B7FF66AD822

Q37728377-27F208CB-51C2-48CF-A12D-C9DCBC13D34A

Q37728377-2904362E-D6B0-4A25-B372-B015E4E32BCB

Q37728377-2F88C48B-5518-4087-B2FB-9601CAE19DA4

Q37728377-3972BC8C-923E-4B18-B0C3-5DC80C8B8A5A

P2888

Q37728377-C40F380F-1214-40C2-AC9D-BD83F12482B6

P304

Q37728377-52155E02-1930-4472-9247-5A7268699EFC

P31

Q37728377-393806BC-7BD2-4F34-AA54-9C3AF9496F3A

P356

Q37728377-1B54D7C6-848C-4B5C-A952-C7175AD5ABBD

P433

Q37728377-CB97FB9F-DC82-484D-91D2-B179BE485609

P478

Q37728377-11D4F6FA-955E-4202-8D50-25CCF5023654

P577

Q37728377-3BA21028-596A-4D95-9892-39773B745410

P5875

Q37728377-8785B940-7776-4303-9B78-22C1D51DAE2D

P6179

Q37728377-856753BF-0E9E-47FE-A75A-411819D3FC7E

P698

Q37728377-9DB2F9FA-6F37-4E6F-87AB-CF3F58C3B86D

P921

Q37728377-514C20BB-45B0-49BB-959B-8F08AE3233AD

P932

Q37728377-1B390A42-A0E0-4185-B6BE-8D87683FE93A

P356

P1433

Acta Pharmacologica Sinica

P1476

Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

@en

P2093

Bing-yan Guo

http://www.w3.org/2001/XMLSchema#string

Feng-ling Meng

http://www.w3.org/2001/XMLSchema#string

Hong Zhou

http://www.w3.org/2001/XMLSchema#string

Li-hui Zhang

http://www.w3.org/2001/XMLSchema#string

Mian Wang

http://www.w3.org/2001/XMLSchema#string

Rui-ying Wang

http://www.w3.org/2001/XMLSchema#string

Yong-gui Deng

http://www.w3.org/2001/XMLSchema#string

Yong-jun Li

http://www.w3.org/2001/XMLSchema#string

Zhan-sheng Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Rocks: multifunctional kinases in cell behaviour

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy.

Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway.

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis.

Rho GTPases, statins, and nitric oxide.

Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts

Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection

P2888

P304

999-1008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2011.54

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51481023

http://www.w3.org/2001/XMLSchema#string

P6179

1005931030

http://www.w3.org/2001/XMLSchema#string

P698

21743486

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4002528

http://www.w3.org/2001/XMLSchema#string